ETRASIMOD IMPROVES QUALITY OF LIFE IN ADULTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 OASIS TRIAL AND OPEN-LABEL EXTENSION

Michael Chiorean  1     Severine Vermeire  2     Julian Panés  3     Laurent Peyrin-Biroulet  4     Bruce E. Sands  5     Stefan Schreiber  6     Gamar Akhundova-Unadkat  7     Snehal U. Naik  8     Christopher J. Rabbat  8     William Sandborn  9    
1 Swedish Medical Center, Seattle, United States
2 University Hospitals Leuven, Flanders, Belgium
3 Hospital Clinic of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
4 University Hospital of Nancy, Vandœuvre-lès-Nancy, France
5 Icahn School of Medicine at Mount Sinai, New York, United States
6 University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
7 Arena Pharmaceuticals Development GmbH, Zug, Switzerland
8 Arena Pharmaceuticals, Inc., San Diego, United States
9 University of California San Diego, La Jolla, United States

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing